Eva Hellqvist

1.3k citations
14 papers · 964 · 1 hit paper · h-index 9

Impact in

  • Immunology top 5%
    • Immune cells in cancer
    • Immune Cell Function and Interaction
    • Phagocytosis and Immune Regulation
    • Immunodeficiency and Autoimmune Disorders
    • Immunotherapy and Immune Responses
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research

Papers in

Eva Hellqvist

14 papers receiving 953 citations

Hit Papers

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis 2016 · 441 citations
4410+3+6Years since publication100200300400

Peers

Eva Hellqvist
Comparison fields: 5 of 74
  • Immunology 497
  • Genetics 243
  • Oncology 249
  • Pathology and Forensic Medicine 157
  • Hematology 68
Replace Shahrzad Jalali with:
Shahrzad Jalali United States
Antonella Vallario Italy
Vinay Sagar United States
Thomas Hawthorne United States
Patricia Amé-Thomas France
Carolina Vicente‐Dueñas Spain
Julie A. McEarchern United States
Danielle Ulanet United States
W Zhang United States
Maike Buchner Germany
Eva Hellqvist relative to Shahrzad Jalali United States Shahrzad Jalali's profile →
Citations per field
00.5×1.5×2.3×
Shahrzad Jalali · 1×
Citations per year

Countries citing papers authored by Eva Hellqvist

Since Specialization
Citations

This map shows the geographic impact of Eva Hellqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellqvist more than expected).

Fields of papers citing papers by Eva Hellqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hellqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellqvist. The network helps show where Eva Hellqvist may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Hellqvist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Hellqvist Line = papers co-authored together Eva Hellqvist links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Hit paper breakdown →
2016441
2 2008199
3 200586
4 201858
5 200855
6 201248
7 201537
8 201314
9 200814
10 20095
11 20134
12 20141
13 20141
14 20121

About Eva Hellqvist

Eva Hellqvist is a scholar working on Genetics, Molecular Biology, Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 14 papers that have together received 964 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Protein Degradation and Inhibitors (2 papers), Lanthanide and Transition Metal Complexes (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Immunology (497 citations), Genetics (243 citations), Oncology (249 citations), Pathology and Forensic Medicine (157 citations) and Hematology (68 citations). Eva Hellqvist has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Anders Rosén, Mikael C. I. Karlsson, Jeffrey V. Ravetch, Rony Dahan, Fubin Li, Silke Sohn, Malin Sund, Søren Brage, Anna‐Maria Georgoudaki and Jeanette Östling. Their work appears in journals such as Blood, British Journal of Cancer, Contrast Media & Molecular Imaging, OncoImmunology and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact